US Stock MarketDetailed Quotes

NMRA Neumora Therapeutics

Watchlist
  • 1.030
  • -0.070-6.36%
Close Mar 28 16:00 ET
  • 1.050
  • +0.020+1.94%
Post 20:01 ET
166.84MMarket Cap-0.67P/E (TTM)

Neumora Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
4.51%263.46M
-44.81%62.92M
34.79%76.65M
51.73%63.82M
53.38%60.07M
85.54%252.1M
271.13%114M
85.82%56.86M
34.32%42.06M
-9.41%39.17M
Selling and administrative expenses
37.52%62.54M
51.39%17.01M
4.93%16.02M
63.50%15.19M
47.86%14.32M
46.12%45.48M
56.16%11.24M
89.53%15.26M
19.36%9.29M
19.74%9.68M
-General and administrative expense
37.52%62.54M
51.39%17.01M
4.93%16.02M
63.50%15.19M
47.86%14.32M
46.12%45.48M
56.16%11.24M
89.53%15.26M
19.36%9.29M
19.74%9.68M
Research and development costs
-2.76%200.93M
-55.32%45.91M
45.74%60.63M
48.40%48.63M
55.19%45.76M
97.26%206.62M
336.88%102.77M
84.49%41.6M
39.28%32.77M
-16.11%29.49M
Operating profit
-4.51%-263.46M
44.81%-62.92M
-34.79%-76.65M
-51.73%-63.82M
-53.38%-60.07M
-85.54%-252.1M
-271.13%-114M
-85.82%-56.86M
-34.32%-42.06M
9.41%-39.17M
Net non-operating interest income expense
20.00%19.93M
-27.59%4.09M
9.67%4.21M
48.15%5.27M
78.34%6.37M
264.20%16.61M
147.09%5.65M
172.97%3.84M
353.83%3.56M
4,050.00%3.57M
Non-operating interest income
20.00%19.93M
-27.59%4.09M
9.67%4.21M
48.15%5.27M
78.34%6.37M
264.20%16.61M
147.09%5.65M
172.97%3.84M
353.83%3.56M
4,050.00%3.57M
Other net income (expense)
54.12%-78K
114.42%15K
-5,600.00%-57K
38.46%-24K
53.85%-12K
-141.98%-170K
-136.24%-104K
99.32%-1K
-124.68%-39K
-124.07%-26K
Other non- operating income (expenses)
54.12%-78K
114.42%15K
-5,600.00%-57K
38.46%-24K
53.85%-12K
-141.98%-170K
-136.24%-104K
99.32%-1K
-124.68%-39K
-124.07%-26K
Income before tax
-3.37%-243.61M
45.77%-58.82M
-36.71%-72.49M
-51.97%-58.58M
-50.80%-53.72M
-80.02%-235.66M
-285.35%-108.46M
-80.71%-53.03M
-26.90%-38.54M
17.23%-35.63M
Income tax
-33.58%178K
0
53K
125K
268K
268K
0
0
Net income
-3.33%-243.79M
45.90%-58.82M
-36.81%-72.55M
-52.30%-58.7M
-50.80%-53.72M
-80.23%-235.93M
-286.31%-108.73M
-80.71%-53.03M
-26.90%-38.54M
17.23%-35.63M
Net income continuous Operations
-3.33%-243.79M
45.90%-58.82M
-36.81%-72.55M
-52.30%-58.7M
-50.80%-53.72M
-80.23%-235.93M
-286.31%-108.73M
-80.71%-53.03M
-26.90%-38.54M
17.23%-35.63M
Minority interest income
Net income attributable to the parent company
-3.33%-243.79M
45.90%-58.82M
-36.81%-72.55M
-52.30%-58.7M
-50.80%-53.72M
-80.23%-235.93M
-286.31%-108.73M
-80.71%-53.03M
-26.90%-38.54M
17.23%-35.63M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-3.33%-243.79M
45.90%-58.82M
-36.81%-72.55M
-52.30%-58.7M
-50.80%-53.72M
-80.23%-235.93M
-286.31%-108.73M
-80.71%-53.03M
-26.90%-38.54M
17.23%-35.63M
Basic earnings per share
57.85%-1.53
45.95%-0.37
60.53%-0.45
-45.87%-0.37
-45.02%-0.34
-321.36%-3.63
-269.57%-0.6846
-490.32%-1.14
-26.90%-0.2537
17.23%-0.2345
Diluted earnings per share
57.85%-1.53
45.95%-0.37
60.53%-0.45
-45.87%-0.37
-45.02%-0.34
-321.36%-3.63
-269.57%-0.6846
-490.32%-1.14
-26.90%-0.2537
17.23%-0.2345
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 4.51%263.46M-44.81%62.92M34.79%76.65M51.73%63.82M53.38%60.07M85.54%252.1M271.13%114M85.82%56.86M34.32%42.06M-9.41%39.17M
Selling and administrative expenses 37.52%62.54M51.39%17.01M4.93%16.02M63.50%15.19M47.86%14.32M46.12%45.48M56.16%11.24M89.53%15.26M19.36%9.29M19.74%9.68M
-General and administrative expense 37.52%62.54M51.39%17.01M4.93%16.02M63.50%15.19M47.86%14.32M46.12%45.48M56.16%11.24M89.53%15.26M19.36%9.29M19.74%9.68M
Research and development costs -2.76%200.93M-55.32%45.91M45.74%60.63M48.40%48.63M55.19%45.76M97.26%206.62M336.88%102.77M84.49%41.6M39.28%32.77M-16.11%29.49M
Operating profit -4.51%-263.46M44.81%-62.92M-34.79%-76.65M-51.73%-63.82M-53.38%-60.07M-85.54%-252.1M-271.13%-114M-85.82%-56.86M-34.32%-42.06M9.41%-39.17M
Net non-operating interest income expense 20.00%19.93M-27.59%4.09M9.67%4.21M48.15%5.27M78.34%6.37M264.20%16.61M147.09%5.65M172.97%3.84M353.83%3.56M4,050.00%3.57M
Non-operating interest income 20.00%19.93M-27.59%4.09M9.67%4.21M48.15%5.27M78.34%6.37M264.20%16.61M147.09%5.65M172.97%3.84M353.83%3.56M4,050.00%3.57M
Other net income (expense) 54.12%-78K114.42%15K-5,600.00%-57K38.46%-24K53.85%-12K-141.98%-170K-136.24%-104K99.32%-1K-124.68%-39K-124.07%-26K
Other non- operating income (expenses) 54.12%-78K114.42%15K-5,600.00%-57K38.46%-24K53.85%-12K-141.98%-170K-136.24%-104K99.32%-1K-124.68%-39K-124.07%-26K
Income before tax -3.37%-243.61M45.77%-58.82M-36.71%-72.49M-51.97%-58.58M-50.80%-53.72M-80.02%-235.66M-285.35%-108.46M-80.71%-53.03M-26.90%-38.54M17.23%-35.63M
Income tax -33.58%178K053K125K268K268K00
Net income -3.33%-243.79M45.90%-58.82M-36.81%-72.55M-52.30%-58.7M-50.80%-53.72M-80.23%-235.93M-286.31%-108.73M-80.71%-53.03M-26.90%-38.54M17.23%-35.63M
Net income continuous Operations -3.33%-243.79M45.90%-58.82M-36.81%-72.55M-52.30%-58.7M-50.80%-53.72M-80.23%-235.93M-286.31%-108.73M-80.71%-53.03M-26.90%-38.54M17.23%-35.63M
Minority interest income
Net income attributable to the parent company -3.33%-243.79M45.90%-58.82M-36.81%-72.55M-52.30%-58.7M-50.80%-53.72M-80.23%-235.93M-286.31%-108.73M-80.71%-53.03M-26.90%-38.54M17.23%-35.63M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -3.33%-243.79M45.90%-58.82M-36.81%-72.55M-52.30%-58.7M-50.80%-53.72M-80.23%-235.93M-286.31%-108.73M-80.71%-53.03M-26.90%-38.54M17.23%-35.63M
Basic earnings per share 57.85%-1.5345.95%-0.3760.53%-0.45-45.87%-0.37-45.02%-0.34-321.36%-3.63-269.57%-0.6846-490.32%-1.14-26.90%-0.253717.23%-0.2345
Diluted earnings per share 57.85%-1.5345.95%-0.3760.53%-0.45-45.87%-0.37-45.02%-0.34-321.36%-3.63-269.57%-0.6846-490.32%-1.14-26.90%-0.253717.23%-0.2345
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Market Insights

U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Cisco
CSCO
60.860
NVIDIA
NVDA
109.670
Broadcom
AVGO
169.120
4
Taiwan Semiconductor
TSM
165.250
5
ASML Holding
ASML
674.580
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More
MicroStrategy Q4 2024 earnings conference call
Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.